A snapshot of novel psychoactive substances (legal highs) use in London

Norman, Claire; Lee, Geraldine

doi:10.1016/j.ienj.2017.06.003

Cited by 3 publications

(4 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a UK-based study, the number of fatalities linked to NPS has risen in recent years from 10 in 2009 to at least 67 deaths in 2015 [49]. Recent research focussed on UK mephedrone fatalities in a sample of individuals aged 16-24 years at the time of death.…”

Section: Nps-related Fatalities In Youngstersmentioning

confidence: 99%

The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review

Orsolini

Chiappini

Corkery

et al. 2019

Expert Review of Neurotherapeutics

View full text Add to dashboard Cite

Introduction: Over the past ten years, a large number of New Psychoactive Substances (NPS) have entered the recreational drug scenario. NPS intake has been associated with health-related risks, and especially so for vulnerable populations such as the youngsters. Currently, most knowledge on the NPS health effects is learnt from both a range of users' reports, made available through the psychonauts' web fora, and from the few published, related toxicity, clinical observations. Areas covered: This paper aims at providing an overview of NPS effects on youngsters' mental health, performing a systematic review of the current related knowledge. Expert opinion: NPS consumption poses serious health risks, due to both a range of unpredictable clinical pharmacological properties and the typical concomitant use of other psychoactive molecules, which can lead to near misses and fatalities. In comparison with adults, the central nervous system of children/adolescents may be more vulnerable to the activity of these molecules, hence raising even further the levels of health-related concerns. Further research is needed, to provide evidence of both short-and long-term effects of NPS, related health risks, and their addiction potential.

show abstract

Section: Nps-related Fatalities In Youngstersmentioning

confidence: 99%

The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review

Orsolini

Chiappini

Corkery

et al. 2019

Expert Review of Neurotherapeutics

View full text Add to dashboard Cite

show abstract

“…Since the change in UK laws, there has been a sharp decline in the numbers of people buying NPS on the high street but an increase in those buying the substances online (Norman and Lee, 2017).…”

Section: Introductionmentioning

confidence: 99%

“…In terms of safety, there have been alerts concerning both non-fatal overdoses and deaths following NPS use. For example, a recent study (Norman and Lee, 2017) suggests that the London Ambulance Service has responded to increasing numbers of NPS-related emergency calls over the last four years and there were over 1,300 Emergency Department presentations associated with NPS in London alone during 2014. However, it is often problematic to identify all the potential NPS emergency presentations due to a lack of information in clinical notes, and consequently there is limited reliable epidemiological evidence relating to levels and type of NPS use.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Novel psychoactive substance use by mental health service consumers: an online survey of inpatient health professionals’ views and experiences

Hughes

Bressington

Sharratt

et al. 2018

ADD

View full text Add to dashboard Cite

Purpose: There is evidence that novel psychoactive substances (NPS) are commonly used by people with severe mental illness. The aim of the study was to undertake a scoping survey to explore inpatient mental health workers' perceptions of NPS use by consumers.Design/methodology: A cross-sectional online survey of mental health professionals.Participants were opportunistically recruited through social media and professional networks.Findings: A total of 98 participants (of 175 who started the survey) were included in the analysis. All reported that some patients had used NPS prior to admission. Over 90% of participants reported observing at least one adverse event relating to NPS use in the previous month. The majority of participants reported that patients had used NPS during their inpatient admission. Three quarters were not clear if their workplace had a policy about NPS.Most wanted access to specific NPS information and training. Participants reported that they lacked the necessary knowledge and skills to manage NPS use in the patients they worked with.Research Limitations/Implications: Whilst we are cautious about the generalizability (due to methodological limitations), our findings provide useful insight into the perceptions of inpatient staff regarding the extent and impact of NPS use including concerns regarding impact on mental and physical health, as well as ease of availability and a need for specific training and guidance.Practical Implications: Mental health professionals require access to reliable and up to date information on changing trends in substance use. Local policies need to include guidance on the safe clinical management of substance use and ensure that NPS information is included.

show abstract

In Silico and In Vitro Investigation into the Next Generation of New Psychoactive Substances

Botha¹

2019

View full text Add to dashboard Cite

A snapshot of novel psychoactive substances (legal highs) use in London

Cited by 3 publications

References 6 publications

The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review

The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review

Novel psychoactive substance use by mental health service consumers: an online survey of inpatient health professionals’ views and experiences

In Silico and In Vitro Investigation into the Next Generation of New Psychoactive Substances

Contact Info

Product

Resources

About